TRIAL OF HIGH-DOSE EDMONSTON-ZAGREB MEASLES VACCINE IN GUINEA-BISSAU: PROTECTIVE EFFICACY
- 1 October 1988
- journal article
- Published by Elsevier in The Lancet
- Vol. 332 (8615), 809-811
- https://doi.org/10.1016/s0140-6736(88)92780-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- TRIAL OF HIGH-DOSE EDMONSTON-ZAGREB MEASLES VACCINE IN THE GAMBIA: ANTIBODY RESPONSE AND SIDE-EFFECTSThe Lancet, 1988
- Decline in measles mortality: nutrition, age at infection, or exposure?BMJ, 1988
- EFFECTS OF DOSE AND STRAIN OF VACCINE ON SUCCESS OF MEASLES VACCINATION OF INFANTS AGED 4-5 MONTHSThe Lancet, 1988
- Vaccinated Children Get Milder Measles Infection: A Community Study from Guinea-BissauThe Journal of Infectious Diseases, 1986
- High measles mortality in infancy related to intensity of exposureThe Journal of Pediatrics, 1986
- IMMUNISATION OF 4-6 MONTH OLD GAMBIAN INFANTS WITH EDMONSTON-ZAGREB MEASLES VACCINEThe Lancet, 1984
- OVERCROWDING AND INTENSIVE EXPOSURE AS DETERMINANTS OF MEASLES MORTALITYAmerican Journal of Epidemiology, 1984